September 30, 2019CirculationOpen Access

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

View Full Paper

Ask AI

Bookmark

Why the study?

Does the interaction between AF duration and CHA2DS2-VASc score risk-stratify patients with AF for stroke and systemic embolism?

Population

Patients with atrial fibrillation (AF)

Authors

RKRachel M. KaplanElectrophysiology JKJodi KoehlerMedtronic (Ireland)PZPaul ZieglerElectrophysiology

Discussion

Member takes

Implication

May further refine SSE risk stratification in AF; leaves open whether it should guide anticoagulation decisions.

Structured PICO

Does the interaction between AF duration and CHA2DS2-VASc score risk-stratify patients with AF for stroke and systemic embolism?

Population

Patients with atrial fibrillation (AF)

Outcome

Stroke and systemic embolism (SSE)hard clinical

The interaction between AF duration and CHA2DS2-VASc score can further risk-stratify patients with AF for stroke and systemic embolism, potentially guiding anticoagulation therapy.

Cite This Study

Kaplan et al. (2019) studied this question.

synapsesocial.com/papers/69cbea344dc32b50d7af5ea4 https://doi.org/10.1161/circulationaha.119.041303

Topics

Atrial fibrillation Persistent AF management Anticoagulation in AF

View Full Paper

Ask AI

Bookmark

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Stroke Risk as a Function of Atrial Fibrillation Duration and CHA 2 DS 2 -VASc Score

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider